measured by the six-week change in the Montgomery-Åsberg Depression Rating Scale. KOASTAL-1, one of three late-stage trials that make up Neumora’s (NASDAQ:NMRA) pivotal KOASTAL program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback